CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project proposes a novel cancer treatment strategy targeting the unique properties of cancer cell mitochondria. By using a specialized drug that accumulates in mitochondria, the aim is to improve treatment efficacy while minimizing side effects.
Cancer is one of the leading causes of death in Europe.
The economic impact of cancer in Europe has been quantified with a total cost of 126 billion €, including healthcare costs and productivity losses.
Although many efforts have been devoted to eradicate cancer, the current treatments are associated with severe side effects and high toxicity.
Alternatively, the next generation of cancer treatments targets only malignant cells, which exhibit unique biochemical hallmarks different from their nor…
UNIVERSIDAD COMPLUTENSE DE MADRID
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
